Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Einstein (Säo Paulo) ; 18: eAO5150, 2020. tab
Article in English | LILACS | ID: biblio-1090068

ABSTRACT

ABSTRACT Objective To verify the association of obesity and infertility related to anovulatory issues. Methods This case-control study was carried out with 52 women, aged 20 to 38 years, divided into two groups (infertile − cases − and fertile − control), seen at outpatient clinics, in the period from April to December, 2017. Results We found significant evidence that obesity negatively affects women's fertility (p=0.017). The group of infertile women was 7.5-fold more likely to be obese than fertile women. Conclusion Strategies that encourage weight control are indicated for women with chronic anovulation, due to hight metabolic activity of adipose tissue.


RESUMO Objetivo Verificar em mulheres a associação entre obesidade e infertilidade relacionada a questões anovulatórias. Métodos Estudo de caso-controle com 52 mulheres, de 20 a 38 anos, divididas em dois grupos (mulheres inférteis − casos − e férteis − controles), atendidas em ambulatórios, no período de abril a dezembro de 2017. Resultados Verificou-se evidência significativa de que a obesidade afeta negativamente na fertilidade das mulheres (p=0,017). O grupo de mulheres inférteis teve 7,5 vezes mais chances de serem obesas quando comparadas às mulheres férteis. Conclusão Estratégias que estimulem o controle do peso são indicadas para mulheres com anovulação crônica devido à elevada atividade metabólica do tecido adiposo.


Subject(s)
Humans , Female , Adult , Young Adult , Infertility, Female/etiology , Anovulation/etiology , Obesity/complications , Exercise/physiology , Case-Control Studies , Anthropometry , Surveys and Questionnaires , Risk Factors , Sedentary Behavior , Infertility, Female/physiopathology , Infertility, Female/metabolism , Anovulation/physiopathology , Anovulation/metabolism , Metabolic Diseases/complications , Metabolic Diseases/physiopathology , Obesity/physiopathology , Obesity/metabolism
2.
Rev. chil. enferm. respir ; 35(1): 33-42, mar. 2019. tab
Article in Spanish | LILACS | ID: biblio-1003644

ABSTRACT

Introducción: La enfermedad respiratoria crónica determina alta morbimortalidad y frecuencia de comorbilidades cardiometabólicas. Evaluamos la asociación entre flujo espiratorio máximo (FEM) y algunas condiciones cardiometabólicas en adultos de una zona semirural, en la medición basal de la cohorte MAUCO (MAUle COhort). Material y Método: Estudio transversal (3.465 adultos, 40-74 años). Se midió el flujo espiratorio máximo (FEM) (mini-Wright, estándar ATS) utilizándose valores de Gregg y Nunn (FEM deteriorado ≤ 80% del teórico). Se obtuvo autorreporte/mediciones de hipertensión arterial (HTA), enfermedad cerebrovascular (ECV), infarto al miocardio (IAM), diabetes mellitus 2 (DM2), presión arterial, glicemia, colesterol, peso y talla. Actividad física y tabaquismo se evaluaron por encuesta, previa aprobación Ética. Se calcularon medidas de asociación, prevalencia y Odds Ratio (OR). Resultados: Muestra de 63,9% de mujeres edad media 55 (± 9) años, escolaridad media 9 (± 4) años. 84,7% tuvo exceso de peso, 81,5% inactividad física 29,4% fumadores actuales. Prevalencia de FEM bajo: 50,6% (IC 95% 48,9-52,3). El autorreporte fue: ACV 2,2% IAM 3,3, sospecha de hipertensión 24% y DM2 2,7%. Los OR crudos fueron significativos en mujeres que autorreportaron HTA, ECV, IAM y autorreporte/sospecha de DM2, y en hombres con autorreporte de ECV, sospecha de DM2 y autorreporte/sospecha de HTA. La asociación se mantuvo post-ajuste en mujeres para autorreporte de IAM y deterioro moderado (OR = 2,49) y severo del FEM (OR = 2,60) y en hombres para sospecha de DM2 y deterioro leve (OR = 5,24) y severo del FEM (OR = 6,19). Conclusiones: FEM resultó significativamente asociado con las enfermedades cardiometabólicas seleccionadas, con efecto sexo- específico para IAM (mujeres) y sospecha de DM2 (hombres). Se constata alta prevalencia de FEM alterado, y de enfermedades cardiometabólicas crónicas en la población estudiada.


Introduction: Chronic respiratory diseases determine high morbimortality and cardiometabolic comorbidities. We evaluated the association between peak expiratory flow (PEF) and cardiometabolic conditions in adults in a semi-rural area, in the baseline of MAUCO cohort (MAUle COhort). Material and Method: Cross-sectional study (3,465 adults, 40-74 years). Peak expiratory flow (PEF) (mini-Wright, ATS standard) was measured (Gregg & Nunn; impaired PEF ≤ 80% predicted). Self-reported/measured hypertension (HT), cerebrovascular disease (CVD), myocardial infarction (AMI), diabetes mellitus 2 (DM2), blood pressure, glycemia, cholesterol, weight and height were obtained. Physical activity and smoking were surveyed, after Ethical approval. Association's measures, prevalence and Odds Ratio (OR) were calculated. Results: Sample of 63.9% of women, mean age 55 (± 9) years, schooling 9 (± 4) years. 84.7% had overweight, 81.5%physical inactivity 29.4% smokers. Low PEF: 50.6% (48.9-52.3). Self-reported was: CVD 2.2% AMI 3.3%, suspicion of hypertension 24% and DM2 2.7%. Crude OR`s were significant for women by self-reported hypertension, stroke, AMI and self-reported/suspicion DM2; in men for self-reported CVD, suspected DM2 and self-reported/suspected hypertension. The association remained post-adjusted in women self-reported AMI -moderate deterioration (OR = 2.49) and severe PEF (OR = 2.60) and in men suspected DM2 and mild (OR = 5.24) and severe deteriorated PEF (OR = 6.19). Conclusions: PEF was significantly associated with cardiometabolic diseases; sex- specific findings for AMI (women) and suspicion of DM2 (men). High prevalence of altered PEF and chronic cardiometabolic diseases were detected among the studied population.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Respiratory Tract Diseases/epidemiology , Cardiovascular Diseases/epidemiology , Maximal Expiratory Flow Rate/physiology , Metabolic Diseases/epidemiology , Respiratory Tract Diseases/physiopathology , Cardiovascular Diseases/physiopathology , Body Mass Index , Comorbidity , Chile/epidemiology , Prevalence , Cross-Sectional Studies , Risk Factors , Analysis of Variance , Sex Distribution , Diabetes Mellitus, Type 2 , Dyslipidemias , Hypertension , Metabolic Diseases/physiopathology , Myocardial Infarction
3.
Int. arch. otorhinolaryngol. (Impr.) ; 23(2): 218-220, 2019. tab
Article in English | LILACS | ID: biblio-1015560

ABSTRACT

Introduction: Menière's disease was described in 1861, but there are still uncertainties regarding its pathophysiology and treatment. Endolymphatic hydrops is recognized as a fundamental pathological characteristic of the disease, as a result of an inadequate absorption of the endolymph. A milder type of endolymphatic hydrops results from an altered chemical composition of the endolymph, due to disorders of the carbohydrate metabolism. Objective: To describe the association of both types of hydrops in patients with Menière disease. Methods: This was a retrospective study of 98 patients with Menière's disease, 62 of whom also presented disorders of the carbohydrate metabolism, and 5 patients with delayed endolymphatic hydrops, 2 of whom also presented disorders of the carbohydrate metabolism. Results: The follow-up of these patients showed that the correction of the metabolic disorders may help in the clinical treatment of Menière's disease and of delayed endolymphatic hydrops, but this does not happen in the more severe types of the diseases. Conclusion: Patients with Menière's disease may present simultaneous disorders of the carbohydratemetabolism, affecting the inner ear. The correction of these disorders helps the clinical treatment but does not preclude the progression of the more severe cases of Menière disease (AU)


Subject(s)
Humans , Male , Female , Carbohydrate Metabolism , Meniere Disease/complications , Metabolic Diseases/complications , Retrospective Studies , Endolymphatic Hydrops/complications , Endolymphatic Hydrops/physiopathology , Ear, Inner/physiopathology , Meniere Disease/etiology , Meniere Disease/physiopathology , Metabolic Diseases/physiopathology
4.
Braz. oral res. (Online) ; 32(supl.1): e68, 2018. tab
Article in English | LILACS | ID: biblio-974474

ABSTRACT

Abstract: Endodontic medicine, which addresses the bidirectional relationship between endodontic infections and systemic diseases, has gained prominence in the field of endodontics. There is much evidence showing that while systemic disease may influence the pathogenesis of endodontic infection, endodontic infection can also cause systemic alterations. These alterations include more severe bone resorption and inflammation in the periapical area as well as enhanced systemic disease symptoms. Similarly, many reports have described the impact of systemic diseases on the tissue responses to dental materials. Conversely, the local use of dental materials may show systemic effects in the form of altered production of biomarkers. Thus, studies to better understand the mechanisms related to those connections are extremely important. In this context, the objective of this review was to analyze and discuss the current literature regarding the connections among these three factors—systemic diseases, endodontic infection, and endodontic dental materials—and determine how these connections may interfere in the systemic health status and the endodontic treatment outcomes, which are represented by periapical wound healing.


Subject(s)
Humans , Periapical Periodontitis/physiopathology , Root Canal Filling Materials/pharmacology , Cardiovascular Diseases/physiopathology , Subcutaneous Tissue/drug effects , Dental Pulp/drug effects , Diabetes Mellitus/physiopathology , Oxides/pharmacology , Risk Factors , Silicates/pharmacology , Calcium Compounds/pharmacology , Aluminum Compounds/pharmacology , Dental Pulp Diseases/physiopathology , Drug Combinations , Metabolic Diseases/physiopathology
5.
Arq. bras. cardiol ; 109(3): 191-198, Sept. 2017. tab
Article in English | LILACS | ID: biblio-887922

ABSTRACT

Abstract Background: Little has been studied on heart rate and its relationship with metabolic disorders. Objective: To identify possible association between heart rate (HR) and metabolic disorders in children and adolescents. Methods: This cross-sectional study evaluated 2.098 subjects, aged between 7 and 17 years. The variables evaluated were: HR, systolic (SBP) and diastolic blood pressure (DBP), pulse pressure (PP), double-product (DP), myocardial oxygen consumption (mVO2), lipids, glucose and uric acid levels, body mass index (BMI) and waist circumference (WC). The values of HR at rest and effort were divided into quartiles. The association between continuous values of HR and cardiometabolic indicators was tested by linear regression. Results: LDL cholesterol presented a significantly higher mean (p = 0.003) in schoolchildren with resting HR greater or equal to 91 bpm, compared to students with less than 75 bpm. Compared with the quartiles of effort HR, SBP, DBP, glucose and uric acid presented high values when HR was greater or equal than 185 bpm. SBP, glucose and HDL cholesterol demonstrated a significant association with resting HR. Uric acid was observed as a predictor of increased effort HR. Conclusion: Schoolchildren with a higher resting HR have higher mean of LDL cholesterol. For effort HR, there was an increase in blood pressure, glucose and uric acid levels. Uric acid has been shown to be a predictor of elevated effort HR.


Resumo Fundamento: Pouco se tem estudado sobre frequência cardíaca e suas relações com alterações metabólicas. Objetivo: Verificar se existe associação entre frequência cardíaca e disfunções metabólicas em crianças e adolescentes. Método: Estudo transversal com 2.098 escolares, com idade entre 7 e 17 anos. As variáveis avaliadas foram: frequência cardíaca (FC), pressão arterial sistólica (PAS), diastólica (PAD) e de pulso (PP), duplo-produto (DP), consumo de oxigênio pelo miocárdio (mVO2), perfil lipídico e glicêmico, níveis de ácido úrico, índice de massa corporal (IMC) e circunferência da cintura (CC). Os valores de FC de repouso e esforço foram divididos em quartis. A associação entre os valores contínuos de FC com indicadores cardiometabólicos foi testada por meio da regressão linear. Resultados: O colesterol LDL apresentou média significativamente superior (p = 0,003) nos escolares com FC de repouso maior ou igual a 91 bpm, em comparação aos escolares que apresentaram menos de 75 bpm. Comparados com os quartis da FC de esforço, a PAS, PAD, glicose e ácido úrico apresentaram valores elevados quando a FC foi igual ou superior a 185 bpm. A PAS, a glicose e o colesterol HDL demonstraram associação significativa com a FC de repouso. Observou-se o ácido úrico como um preditor do aumento da FC de esforço. Conclusão: Escolares com FC de repouso mais elevada apresentam médias superiores de colesterol LDL. Para FC de esforço, observou-se elevação na pressão arterial, nos níveis de glicose e de ácido úrico. O ácido úrico demonstrou ser preditor da elevação da FC de esforço.


Subject(s)
Humans , Male , Female , Child , Adolescent , Rest/physiology , Physical Exertion/physiology , Metabolic Diseases/diagnosis , Uric Acid/blood , Blood Pressure/physiology , Biomarkers/blood , Cross-Sectional Studies , Glycemic Index/physiology , Heart Rate/physiology , Lipids/blood , Metabolic Diseases/physiopathology , Metabolic Diseases/blood
6.
Biol. Res ; 49: 1-9, 2016. ilus, graf
Article in English | LILACS | ID: biblio-950840

ABSTRACT

The carotid body (CB) is the main peripheral chemoreceptor that senses the arterial PO2, PCO2 and pH. In response to hypoxemia, hypercapnia and acidosis, carotid chemosensory discharge elicits reflex respiratory, autonomic and cardiovascular adjustments. The classical construct considers the CB as the main peripheral oxygen sensor, triggering reflex physiological responses to acute hypoxemia and facilitating the ventilatory acclimation to chronic hypoxemia at high altitude. However, a growing body of experimental evidence supports the novel concept that an abnormally enhanced CB chemosensory input to the brainstem contributes to overactivation of the sympathetic nervous system, and consequent pathology. Indeed, the CB has been implicated in several diseases associated with increases in central sympathetic outflow. These include hypertension, heart failure, sleep apnea, chronic obstructive pulmonary disease and metabolic syndrome. Indeed, ablation of the CB has been proposed for the treatment of severe and resistant hypertension in humans. In this review, we will analyze and discuss new evidence supporting an important role for the CB chemoreceptor in the progression of autonomic and cardiorespiratory alterations induced by heart failure, obstructive sleep apnea, chronic obstructive pulmonary disease and metabolic syndrome.


Subject(s)
Humans , Sympathetic Nervous System/physiopathology , Carotid Body/physiopathology , Sleep Apnea, Obstructive/physiopathology , Pulmonary Disease, Chronic Obstructive/physiopathology , Heart Failure/physiopathology , Metabolic Diseases/physiopathology , Carotid Body/chemistry , Risk Factors , Sleep Apnea, Obstructive/etiology , Pulmonary Disease, Chronic Obstructive/etiology , Heart Failure/etiology , Metabolic Diseases/etiology
7.
Arq. bras. cardiol ; 101(2): 176-182, ago. 2013. tab
Article in Portuguese | LILACS | ID: lil-685390

ABSTRACT

FUNDAMENTO: O Índice Internacional de Função Erétil tem sido proposto como método de avaliação da função sexual, auxiliando no diagnóstico e na classificação da disfunção erétil. No entanto, não foi realizada a validação do IIFE para a língua portuguesa. OBJETIVO: Validar o Índice Internacional de Função Erétil em pacientes portadores de doenças cardiopulmonares e metabólicas. MÉTODOS: A amostra foi composta por 108 participantes portadores de doenças cardiopulmonares e metabólicas de dois programas de reabilitação cardiopulmonar e metabólica (RCPM) do sul do Brasil. A avaliação da clareza do instrumento foi realizada por meio de escala com variação de 0-10, a validação de construto foi realizada pela análise fatorial confirmatória (KMO = 0,85, Barllet p < 0,001), a consistência interna foi analisada pelo alfa de Cronbach. Foram analisados, ainda, os preceitos de reprodutibilidade e confiabilidade interavaliadores por meio do teste reteste. RESULTADOS: Os itens foram julgados muito claros, com médias superiores a 9. A consistência interna resultou em 0,89. A maioria das questões relacionou-se corretamente com seus respectivos domínios, com exceção das três questões do domínio satisfação sexual e uma questão relacionada à função erétil. Os itens apresentaram excelente estabilidade de medida e concordância substancial quase perfeita. CONCLUSÃO: Demonstrou-se que o IIFE é válido e bem compreendido por pacientes que participam de programa de reabilitação cardiopulmonar e metabólica.


BACKGROUND: The International Index of Erectile Function has been proposed as a method for assessing sexual function assisting the diagnosis and classification of erectile dysfunction. However, IIEF was not validated for the Portuguese language. OBJECTIVE: Validate the International Index of Erectile Function in patients with cardiopulmonary and metabolic diseases. METHODS: The sample consisted of 108 participants of to Cardiopulmonary and Metabolic program Rehabilitation (CPMR) in southern Brazil. The clarity assessment of the instrument was performed using a scale ranging from zero to 10. The construct validity was carried out by confirmatory factor analysis (KMO = 0.85; Barllet p < 0.001), internal consistency by Cronbach's alpha and reproducibility and interrater reliability via the test retest method. RESULTS: The items were considered very clear with averages superior to 9. The internal consistency resulted in 0.89. The majority of items related correctly with their domains, with exception of three questions from sexual satisfaction domain, and one from erectile function. All items showed excellent stability of measure and substantial to almost perfect agreement. CONCLUSION: The present study showed that the IIEF is valid and reliable for use in participants of a cardiopulmonary and metabolic rehabilitation program.


Subject(s)
Humans , Male , Middle Aged , Cross-Cultural Comparison , Cardiovascular Diseases/physiopathology , Erectile Dysfunction/diagnosis , Lung Diseases/physiopathology , Metabolic Diseases/physiopathology , Surveys and Questionnaires , Brazil , Cross-Sectional Studies , Cultural Characteristics , Erectile Dysfunction/physiopathology , Language , Psychometrics , Reproducibility of Results , Risk Factors , Severity of Illness Index , Socioeconomic Factors
8.
Braz. j. med. biol. res ; 44(9): 920-932, Sept. 2011. ilus
Article in English | LILACS | ID: lil-599670

ABSTRACT

The endothelium plays a vital role in maintaining circulatory homeostasis by the release of relaxing and contracting factors. Any change in this balance may result in a process known as endothelial dysfunction that leads to impaired control of vascular tone and contributes to the pathogenesis of some cardiovascular and endocrine/metabolic diseases. Reduced endothelium-derived nitric oxide (NO) bioavailability and increased production of thromboxane A2, prostaglandin H2 and superoxide anion in conductance and resistance arteries are commonly associated with endothelial dysfunction in hypertensive, diabetic and obese animals, resulting in reduced endothelium-dependent vasodilatation and in increased vasoconstrictor responses. In addition, recent studies have demonstrated the role of enhanced overactivation ofβ-adrenergic receptors inducing vascular cytokine production and endothelial NO synthase (eNOS) uncoupling that seem to be the mechanisms underlying endothelial dysfunction in hypertension, heart failure and in endocrine-metabolic disorders. However, some adaptive mechanisms can occur in the initial stages of hypertension, such as increased NO production by eNOS. The present review focuses on the role of NO bioavailability, eNOS uncoupling, cyclooxygenase-derived products and pro-inflammatory factors on the endothelial dysfunction that occurs in hypertension, sympathetic hyperactivity, diabetes mellitus, and obesity. These are cardiovascular and endocrine-metabolic diseases of high incidence and mortality around the world, especially in developing countries and endothelial dysfunction contributes to triggering, maintenance and worsening of these pathological situations.


Subject(s)
Animals , Humans , Rats , Cardiovascular Diseases/physiopathology , Endocrine System Diseases/physiopathology , Endothelium, Vascular/physiopathology , Metabolic Diseases/physiopathology , Nitric Oxide Synthase Type III/metabolism , Cardiovascular Diseases/metabolism , Diabetes Mellitus/metabolism , Diabetes Mellitus/physiopathology , Endocrine System Diseases/metabolism , Endothelium, Vascular/metabolism , Endothelium-Dependent Relaxing Factors/physiology , Nitric Oxide/biosynthesis , Obesity/metabolism , Obesity/physiopathology
9.
Femina ; 37(5): 288-291, maio 2009.
Article in Portuguese | LILACS | ID: lil-539348

ABSTRACT

A síndrome do ovário policístico é a endocrinopatia ginecológica mais frequente das mulheres em idade reprodutiva, clinicamente caracterizada pela presença de anovulação crônica hiperandrogênica, hirsutismo e infertilidade. Além das alterações reprodutivas, uma proporção considerável das portadoras da síndrome apresenta anormalidades metabólicas como: resistência à insulina e obesidade, com aumento significativo do risco para o desenvolvimento de intolerância à glicose; diabetes mellitus e doença cardiovascular. No entanto, os mecanismos fisiopatológicos que vinculam a obesidade, a resistência à insulina e os demais distúrbios metabólicos presentes na síndrome do ovário policístico ainda não estão completamente esclarecidos. Estudos recentes sugerem que a adiponectina, uma proteína secretada especificamente pelo tecido adiposo, que apresenta propriedades antiaterogênicas, anti-inflamatórias e sensibilizadora à ação da insulina, poderia apresentar um importante papel integrador na patogênese desses distúrbios metabólicos.


Polycystic ovary syndrome is the most common gynecologic endocrinopathy of reproductive age women. It is clinically characterized by hyperandrogenic chronic anovulation, hisrutism and infertility. In addition to reproductive alterations, a significant proportion of polycystic ovary syndrome women display metabolic abnormalities such as insulin resistance and adiposity, predisposing to greater risk of developing glucose intolerance; diabetes mellitus and cardiovascular disease. However, the physiopathologic mechanisms linking obesity, insulin resistance and the other polycystic ovary syndrome metabolic disturbances are not completely understood. Recent studies suggest that adiponectin, a protein specifically secreted by adipose tissue and which has antiatherogenic, anti-inflammatory and insulin-sensitizing properties, could play an important and integrative role in the pathogenesis of these metabolic disturbances.


Subject(s)
Female , Adiponectin/blood , Adiponectin/therapeutic use , Metabolic Diseases/physiopathology , Insulin Resistance , Obesity/metabolism , Polycystic Ovary Syndrome/metabolism , Polycystic Ovary Syndrome/blood , Adipose Tissue/metabolism
10.
Femina ; 35(2): 75-82, fev. 2007. ilus, tab
Article in Portuguese | LILACS | ID: lil-471272

ABSTRACT

São discutidos os critérios de diagnóstico da Síndrome dos ovários policísticos ressaltando a interferência do emprego de critérios não normatizados na vulgarização do diagnóstico. Especial menção é feita ao aspecto metabólico e vascular associado e suas repercussões para o futuro reprodutivo das pacientes portadoras da Síndrome dos ovários policísticos


Subject(s)
Humans , Female , Clinical Laboratory Techniques , Metabolic Diseases/physiopathology , Endothelium, Vascular , Laser-Doppler Flowmetry , Polycystic Ovary Syndrome/diagnosis , Polycystic Ovary Syndrome/metabolism , Polycystic Ovary Syndrome
11.
J. bras. med ; 90(6): 13-20, jun. 2006.
Article in Portuguese | LILACS | ID: lil-480231

ABSTRACT

Coma pode ser definido como um estado de não-responsividade e não-reatividade do organismo, e o seu diagnóstico é feito quando temos uma Escala de Coma de Glasgow menor ou igual a 7. De acordo com a literatura médica, aproximadamente 60 por cento dos casos de coma têm origem em desordens metabólicas, que levam a alterações no suprimento de metabólitos ou modificações da excitabilidade neuronal.


Subject(s)
Male , Female , Coma , Metabolic Diseases/complications , Metabolic Diseases/physiopathology , Coma, Post-Head Injury , Diabetic Coma , Glasgow Coma Scale
12.
Iranian Journal of Diabetes and Lipid Disorders. 2005; 4 (2): 71-78
in Persian | IMEMR | ID: emr-71147

ABSTRACT

Homocysteine is regarded as a risk factor for metabolic syndrome and cardiovascular diseases. It is of great importance to determine exact risk factors of these disorders because of their high prevalence. The 25-64 year old individuals in 17th district of Tehran were studied. It was designed according to the WHO MONICA [Multinational Monitoring of Trends and Determinants in Cardiovascular Disease] project using the ATP III criteria. Homocysteine levels higher than 15 mmol/l and Folate and vitamin B12 lower than 11 nmol/l and 185 pmol/l, respectively were considered as abnormal. Of the whole population, prevalence of abnormal homocysteine, Folic acid and vitamin B12 was 54.5%, 98.2% and 27%, respectively. Homocysteine levels were higher in men than women [P= 0.026]. None of the differences between the means of these three risk factors were statistically significant in people with and without the metabolic syndrome. The only significant difference was higher homocysteine levels in women with metabolic syndrome [P= 0.010]. According to this study, hyperhomocysteinemia and Folate and vitamin B12 deficiency are more prevalent in our population. But there was no correlation between these factors and risk of metabolic syndrome. Because of the controversy about this issue and high prevalence of cardiovascular diseases in our country, further studies are suggested


Subject(s)
Humans , Metabolic Diseases/physiopathology , Metabolic Diseases/etiology , Cardiovascular Diseases , Risk Factors , Prevalence , Folic Acid/blood , Vitamin B 12/blood , Metabolic Syndrome
13.
Rev. cuba. endocrinol ; 13(3)sep.-dic. 2002. tab, graf
Article in Spanish | LILACS, CUMED | ID: lil-388337

ABSTRACT

El síndrome metabólico fue reconocido hace más de 80 años en la literatura médica y ha recibido diversas denominaciones a través del tiempo. No se trata de una única enfermedad sino de una asociación de problemas de salud que pueden aparecer de forma simultánea o secuencial en un mismo individuo, causados por la combinación de factores genéticos y ambientales asociados al estilo de vida en los que la resistencia a la insulina se considera el componente patogénico fundamental. La presencia de síndrome metabólico se relaciona con un incremento significativo de riesgo de diabetes, enfermedad coronaria y enfermedad cerebrovascular, con disminución en la supervivencia, en particular, por el incremento unas 5 veces en la mortalidad cardiovascular. En la presente revisión se trataron aspectos relacionados con su patogenia, epidemiología y diagnóstico, se enfatizó además en la importancia de identificar y tratar oportunamente las comorbilidades presentes en estos pacientes como estrategia en la prevención de enfermedades cardiovasculares(AU)


Subject(s)
Humans , Male , Female , Heart Diseases/prevention & control , Life Style , Metabolic Diseases/diagnosis , Metabolic Diseases/physiopathology , Metabolic Diseases/epidemiology
16.
Rev. bras. anal. clin ; 31(2): 63-68, 1999. ilus, tab
Article in Portuguese | LILACS | ID: lil-522849

ABSTRACT

A enzima fosforilase do glicogênio (E.C.2.4.1.1.) catalisa a quebra fosforilítica das ligações a(1,4) do glicogênio, produzindo glicose 1 –fosfato e uma dextrina limite. Esta enzima existe sob a forma inativa (b), desfosforilada, e a forma (a), ativa e fosforilada. O déficit em fosforilase é transmitido pelo modo autossômico recessivo e é denominado de doença de Hers, quando o órgão atingido é o fígado e doença de Mc Ardie, quando a musculatura esquelética é afetada. Neste trabalho é desenvolvido um método para a determinação da atividade da fosforilase do glicogênio possibilitando, assim, o diagnóstico laboratorial das doenças de estocagem de glicogênio produzidas pela deficiência desta enzima.


Subject(s)
Humans , Male , Female , Metabolic Diseases/physiopathology , Muscular Diseases/physiopathology , Glycogen Phosphorylase , Glycogen Storage Disease
SELECTION OF CITATIONS
SEARCH DETAIL